Our top ten news from 27 January 2022 to 03 February 2022 (ranked according to popularity).<\/p>\n
Thursday 27 January 2022<\/p>\n
In this week's Weekly Insights:-Risks To Consider-Conviction Calls-Backlog In MessagesRisks To ConsiderBy Rudi Filapek-Vandyck, Editor FNArenaLet's start with the good news. Historical data analysis suggests the final week of January and the first ten trading days into Fe<\/p>\n<\/div>\n
Friday 28 January 2022<\/p>\n
Weekly Broker Wrap: In Brief: Best of the banks; preferred building products; 2022 gaming stocks and non-bank lenders at a discount<\/p>\n<\/div>\n
Monday 31 January 2022<\/p>\n
Brokers remain positive on the outlook for ResMed due to a new product launch and the potential for both increased market share and the easing of supply chain pressures<\/p>\n<\/div>\n
Tuesday 01 February 2022<\/p>\n
Given the risk of a "dead cat" bounce, Michael Gable of Fairmont Equities does not advocate buying anything right now, but suggests Macquarie Group is worth watching<\/p>\n<\/div>\n
Monday 31 January 2022<\/p>\n
Extra Edition of the Broker Call Report<\/p>\n<\/div>\n
Monday 31 January 2022<\/p>\n
Weekly update on stockbroker recommendation, target price, and earnings forecast changes<\/p>\n<\/div>\n
Friday 28 January 2022<\/p>\n
Saxo Bank is predicting a resurgence of the fossil fuel sector in the coming year amidst a global energy crisis driven by the global focus on future energy solutions. Impacts will likely be far reaching, with consumer goods pricing set to rise and shareholders in commodities producers benefiting from elevated demand<\/p>\n<\/div>\n
Thursday 27 January 2022<\/p>\n
The Chartist remains longer term bullish on the S&P500, but for now is staying right out of it<\/p>\n<\/div>\n